IAIM
MRNA icon

International Assets Investment Management’s Moderna MRNA Stock Holding History

International Assets Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30K Sell
414
-1,369
-77% -$70.8K ﹤0.01% 1481
2026
Q1 		$89.2K Sell
1,783
-541
-23% -$25.2K 0.01% 1049
2025
Q4 		$68.5K Buy
+2,324
New +$63.1K ﹤0.01% 1117
2024
Q4 		– Sell
-319,514
Closed -$4.78K – 1450
2024
Q3 		$4.78K Buy
319,514
+316,552
+10,687% +$29.1M 0.01% 581
2024
Q2 		$352K Sell
2,962
-900
-23% -$114K 0.03% 491
2024
Q1 		$408K Sell
3,862
-36
-0.9% -$3.63K 0.04% 424
2023
Q4 		$388K Sell
3,898
-1,950
-33% -$164K 0.05% 410
2023
Q3 		$582K Buy
5,848
+1,054
+22% +$118K 0.08% 234
2023
Q2 		$582K Sell
4,794
-1,817
-27% -$242K 0.08% 242
2023
Q1 		$1.02M Sell
6,611
-5,619
-46% -$927K 0.15% 142
2022
Q4 		$2.2M Buy
12,230
+4,878
+66% +$798K 0.23% 97
2022
Q3 		$869K Sell
7,352
-379
-5% -$57.5K 0.19% 123
2022
Q2 		$1.1K Buy
7,731
+522
+7% +$74.6K 0.1% 103
2022
Q1 		$1.24M Sell
7,209
-5,034
-41% -$848K 0.22% 99
2021
Q4 		$3.11M Sell
12,243
-4,164
-25% -$1.22M 0.54% 29
2021
Q3 		$6.31M Buy
16,407
+7,021
+75% +$2.59M 1.12% 10
2021
Q2 		$2.21M Sell
9,386
-7,492
-44% -$1.34M 0.41% 44
2021
Q1 		$1.96M Buy
16,878
+7,297
+76% +$1.06M 0.18% 118
2020
Q4 		$1M Buy
9,581
+2,134
+29% +$216K 0.18% 116
2020
Q3 		$527K Sell
7,447
-4,310
-37% -$301K 0.13% 158
2020
Q2 		$755K Buy
+11,757
New +$644K 0.18% 115

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

International Assets Investment Management's MRNA Position: Q2 2026 in Review

International Assets Investment Management reduced its Moderna (MRNA) stake by 77% in Q2 2026, selling an estimated $70.8K and leaving 414 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

International Assets Investment Management first reported a position in MRNA in Q2 2020 and has held it in 21 quarters since. The position peaked at $6.31M in Q3 2021. 399 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • International Assets Investment Management held 414 shares of Moderna worth $30K as of Q2 2026.
  • International Assets Investment Management sold 1,369 Moderna shares in Q2 2026, an estimated $70.8K.
  • Moderna made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1481 holding.
  • International Assets Investment Management first reported a position in Moderna in Q2 2020 and has held it in 21 quarters since.
  • International Assets Investment Management's Moderna position peaked at $6.31M in Q3 2021.
  • 399 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.